Paper19101136
In vitro study on the individual and synergistic cytotoxicity of adriamycin and selenium nanoparticles against Bel7402 cells with a quartz crystal microbalance.
Tan L and 6 others. Biosens Bioelectron, 2009. Cited by 74 papers, by iCite.
Cite this record
ConductScience Library. In vitro study on the individual and synergistic cytotoxicity of adriamycin and selenium nanoparticles against Bel7402 cells with a quartz crystal microbalance. Papers, record 19101136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/19101136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vitro study on the individual and synergistic cytotoxicity of adriamycin and selenium nanoparticles against Bel7402 cells with a quartz crystal microbalance.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Combined Chemotherapy Protocols | Major topic |
| Apoptosis | Major topic |
| Doxorubicin | Major topic |
| Liver Neoplasms | Major topic |
| Micro-Electrical-Mechanical Systems | Major topic |
| Selenium | Major topic |
| Cell Line, Tumor | |
| Drug Synergism | |
| Humans | |
| Nanoparticles | |
| Treatment Outcome |
Source PubMed
Cited by20
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 74 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41214729 | Advances in biomedical applications of Se-based nanozymes. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/41214729 | PubMed |
| 40765417 | Advances in selenium-based nanomedicines for cardiovascular disease therapy: mechanisms, current trends, and prospects. | Nanomedicine (Lond) | 2025 | https://conductscience.org/library/papers/40765417 | PubMed |
| 40138104 | Targets and Potential Mechanism of Chondroitin Sulfate A-selenium Nanoparticle on Kashin-Beck Disease Chondrocytes. | Biol Trace Elem Res | 2025 | https://conductscience.org/library/papers/40138104 | PubMed |
| 39875778 | Selenium-Enriched Lactiplantibacillus plantarum ZZU 8-12 Regulates Intestinal Microbiota and Inhibits Acute Liver Injury. | Probiotics Antimicrob Proteins | 2025 | https://conductscience.org/library/papers/39875778 | PubMed |
| 38796570 | Recent advances in the therapeutic applications of selenium nanoparticles. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38796570 | PubMed |
| 38584179 | Species selective concentration and determination of nano-selenium and inorganic selenium species in environmental waters by micropore membrane filtration and ICP-MS. | Anal Bioanal Chem | 2024 | https://conductscience.org/library/papers/38584179 | PubMed |
| 38398553 | Selenium Nanoparticles: A Comprehensive Examination of Synthesis Techniques and Their Diverse Applications in Medical Research and Toxicology Studies. | Molecules | 2024 | https://conductscience.org/library/papers/38398553 | PubMed |
| 37445628 | Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37445628 | PubMed |
| 36935493 | Theranostic applications of selenium nanomedicines against lung cancer. | J Nanobiotechnology | 2023 | https://conductscience.org/library/papers/36935493 | PubMed |
| 36819694 | Trends and recent progresses of selenium nanoparticles as novel autophagy regulators for therapeutic development. | Front Nutr | 2023 | https://conductscience.org/library/papers/36819694 | PubMed |
| 35300372 | Synthesis of silymarin-selenium nanoparticle conjugate and examination of its biological activity in vitro. | ADMET DMPK | 2021 | https://conductscience.org/library/papers/35300372 | PubMed |
| 33849555 | Selenium nanoparticles produce a beneficial effect in psoriasis by reducing epidermal hyperproliferation and inflammation. | J Nanobiotechnology | 2021 | https://conductscience.org/library/papers/33849555 | PubMed |
| 28991962 | Redox-active nanomaterials for nanomedicine applications. | Nanoscale | 2017 | https://conductscience.org/library/papers/28991962 | PubMed |
| 26229727 | Epirubicin-[Anti-HER2/neu] Synthesized with an Epirubicin-(C13-imino)-EMCS Analog: Anti-Neoplastic Activity against Chemotherapeutic-Resistant SKBr-3 Mammary Carcinoma in Combination with Organic Selenium. | J Cancer Ther | 2011 | https://conductscience.org/library/papers/26229727 | PubMed |
| 26005349 | Anticancer activity of biostabilized selenium nanorods synthesized by Streptomyces bikiniensis strain Ess_amA-1. | Int J Nanomedicine | 2015 | https://conductscience.org/library/papers/26005349 | PubMed |
| 25821636 | Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se]-Methylselenocysteine. | J Cancer Ther | 2015 | https://conductscience.org/library/papers/25821636 | PubMed |
| 25692115 | Effects of combination therapy of docetaxel with selenium on the human breast cancer cell lines MDA-MB-231 and MCF-7. | Ann Surg Treat Res | 2015 | https://conductscience.org/library/papers/25692115 | PubMed |
| 25322894 | Recovery of adriamycin induced mitochondrial dysfunction in liver by selenium. | Cytotechnology | 2015 | https://conductscience.org/library/papers/25322894 | PubMed |
| 23055734 | Co-nanoencapsulation of magnetic nanoparticles and selol for breast tumor treatment: in vitro evaluation of cytotoxicity and magnetohyperthermia efficacy. | Int J Nanomedicine | 2012 | https://conductscience.org/library/papers/23055734 | PubMed |
| 21997385 | Acoustic sensors as a biophysical tool for probing cell attachment and cell/surface interactions. | Cell Mol Life Sci | 2012 | https://conductscience.org/library/papers/21997385 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/19101136
GET https://conductscience.org/api/papers/v1/19101136/authors